April 9, 2018 Comments Off on FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars Posted in: Insights By Ed Lamb, DrugPatentWatch writer Under a new commissioner dedicated to bolstering competition to reduce prices, the agency is redoing a raft of rules and guidances to speed ANDA approvals…
The post FDA Pushes to Reduce Single-Source Generics, I…
April 2, 2018 Comments Off on When should you outsource drug development Posted in: Uncategorized
For pharmaceutical companies in flux, contract services are playing a pivotal and more diverse role in the drug development process. The rapid growth of the contract research organization or CRO…
The post When should you outsource drug developmen…
